Author information:
(1)Department of Hematology and Medical Oncology, University Medicine of 
Goettingen, Germany.
(2)Department of Hematology and Oncology, Technical University of Munich, 
Germany.
(3)Department of Hematology and Oncology, University of Dresden, Germany.
(4)Department of Hematology and Oncology, University of Duesseldorf, Germany.
(5)Department of Hematology and Oncology, University Hospital of Mannheim, 
Germany.
(6)Department of Hematology and Oncology, Marienhospital, Duesseldorf, Germany.
(7)Department of Hematology and Oncology, University of Freiburg Medical Center, 
Freiburg, Germany.
(8)Department of Hematology, Stanford University Cancer Center, Stanford, CA.
(9)University of Rochester Medical Center, Rochester, NY.
(10)Institut De Recerca Contra La Leukemia Josep Carreras, Badalona, Spain.
(11)Sonora Quest Laboratories, Phoenix, AZ.
(12)Tokyo Medical University, Tokyo, Japan.
(13)Section of Hematology and Oncology, University of Chicago, Chicago, IL.
(14)Hanusch Hospital Boltzmann Institute for Leukemia Research, Vienna, Austria.
(15)Third Medical Department for Hematology and Oncology and L. Boltzmann 
Cluster Oncology, Hanusch Hospital, Vienna, Austria.
(16)Department of Human Genetics, University of Düsseldorf, Düsseldorf, Germany.
(17)Department of Hematology, Oncology and Clinical Immunology, St. Johannes 
Hospital, Duisburg, Germany.
(18)Department of Internal Medicine, Innsbruck Medical University, Innsbruck, 
Austria.
(19)Department of Internal Medicine I, Division of Hematology and Hemostaseology 
and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, 
Austria.
(20)Department of Medical Genetics, Medical University of Vienna, Vienna, 
Austria.